Targacept discontinues bladder drug, shares plunge
(Reuters) - Targacept Inc said it was stopping development of a drug to treat overactive bladder after it failed to show significant reduction in incontinence in a mid-stage study. (Source: Reuters: Health)
Source: Reuters: Health - July 28, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Targacept to Discontinue Overactive Bladder Program
Targacept Inc. said it would abandon further development of TC-5214 as a treatment for overactive bladder after seeing disappointing results in a midstage study. (Source: WSJ.com: Health)
Source: WSJ.com: Health - July 28, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news
Botox Helps Overactive Bladder Beyond 2 YearsBotox Helps Overactive Bladder Beyond 2 Years
In the first long-term study of Botox for overactive bladder, efficacy and safety persisted for a median of 2.4 years with no additional safety issues, report researchers. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 24, 2014 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
MS Bladder Problems Show Up Early and Often
(MedPage Today) -- Nearly 80% of multiple sclerosis patients in a large registry reported overactive bladder symptoms, and one-third of a separate cohort of newly diagnosed patients also showed urinary dysfunction, researchers reported here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - May 30, 2014 Category: Journals (General) Source Type: news
Botulinum Toxin Soothes Neurogenic Bladder SymptomsBotulinum Toxin Soothes Neurogenic Bladder Symptoms
In 2 separate studies, botulinum toxin was found to be beneficial for control of overactive bladder. One study suggests that it could supplant some surgical procedures. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 20, 2014 Category: Consumer Health News Tags: Urology News Source Type: news
Urine is NOT sterile as study finds healthy people have bacteria in bladders
Researchers at Loyola University Chicago say the findings may also help the 15 per cent of women who suffer from overactive bladder syndrome. (Source: the Mail online | Health)
Source: the Mail online | Health - May 19, 2014 Category: Consumer Health News Source Type: news
'Sterile' Urine May Be a Myth
Bacteria lurked even in samples from healthy women, researchers say
Source: HealthDay
Related MedlinePlus Pages: Overactive Bladder, Urine and Urination, Women's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 19, 2014 Category: Consumer Health News Source Type: news
Study debunks common myth that urine is sterile: Bacterial differences found in urine of healthy women and women with overactive bladder
This study also revealed that bladder bacteria in healthy women differ from the bladder bacteria in women affected by overactive bladder, which causes a sudden need to urinate. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 18, 2014 Category: Science Source Type: news
Bacteria in urine could contribute to overactive bladder
(American Society for Microbiology) Contrary to popular belief, urine is not sterile and the bacteria in it may be associated with overactive bladder in some women, according to research presented today at the annual meeting of the American Society for Microbiology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 18, 2014 Category: Biology Source Type: news
Axonics raises $33M for its neuromodulation tech
Alfred Mann Foundation spinout Axonics Modulation Technologies raises nearly $33 million in a Series A round for its neuromodulation technology.
Axonics Modulation Technologies said it drummed up a $32.6 million Series A round for the neuromodulation technology it's developing to treat chronic pain and overactive bladder.
Irvine, Calif.-based Axonics said the round was led by Edmond de Rothschild Investment Partners and included NeoMed Management, Legend Capital and "a select group of private individuals."
Axonics Modulation Technologies, Vessix Vascular Inc.News Well, Funding Roundup, Neuro...
Source: Mass Device - March 28, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news
There May Be Many Drug-Free Solutions for Treating Overactive Bladder,...
As Consumer Reports Best Buy Drugs advises women to consider alternatives before buying Oxytrol to treat overactive bladder, Dianna Malkowski of The CareGiver Partnership says sometimes the best...(PRWeb February 26, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11612880.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 27, 2014 Category: Pharmaceuticals Source Type: news
Uroplasty lands reimbursement for overactive bladder treatment
Leading South East Pennsylvania insurance provider Independence Blue Cross agrees to cover Uroplasty's Urgent PC overactive bladder treatment device.
Uroplasty (NSDQ:UPI) notched a reimbursement win with Independence Blue Cross now covering the Urgent PC device.
Independence Blue Cross, Uroplasty Inc.News Well, Minnesota, Reimbursement, Urologyread more (Source: Mass Device)
Source: Mass Device - February 19, 2014 Category: Medical Equipment Authors: Chris Walker Source Type: news
Targacept completes patient recruitment for Phase IIb overactive bladder study
US-based biopharmaceutical firm Targacept has completed patient recruitment for its Phase IIb clinical trial of TC-5214 for the treatment for overactive bladder (OAB). (Source: Drug Development Technology)
Source: Drug Development Technology - February 11, 2014 Category: Pharmaceuticals Source Type: news
Short-Form OAB questionnaire validated
Researchers from the USA have developed a short form version of the overactive bladder questionnaire, which they say can capture the full spectrum of symptom bother and quality of life impact, while being more convenient than the full version of the test. (Source: MedWire News - Urology)
Source: MedWire News - Urology - February 10, 2014 Category: Urology & Nephrology Source Type: news
Uroplasty Appoints Suranjan Roychowdhury, Ph.D. to New Vice President of Research and Development and Clinical Affairs Role
Experienced Executive in Development and Commercialization of Medical Devices to Assume Key New Position
MINNEAPOLIS, Jan. 27, 2014 -- (Healthcare Sales & Marketing Network) -- Uroplasty, Inc. (UPI), a medical device company that develops, manufactures... Devices, Urology, PersonnelUroplasty, tibial nerve stimulation, overactive bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 27, 2014 Category: Pharmaceuticals Source Type: news
